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The objective was to evaluate the technological processing (protection strategies and storage conditions) influ-
ence on viability, on probiotic properties and adsorbent aflatoxin B1 capacity of S. boulardii RC009. Also, the yeast
biological safety was evaluated. Lyophilisation (DL) and encapsulation þ lyophilisation (EL) were conducted.
Yeast protected with maltodextrin (M) or WPC stored at 4 C reduced 1 and 2 log the viability, respectively. Yeast
protected with M stored at 25 C reduced 1 log after 70 d; with WPC the viability significantly reduced 3 log after
30 d. Technological processing improved the coaggregation’s capacity with pathogens and DL process allowed the
greatest AFB1 adsorption. S. boulardii 106 cells/mL were no toxic to Vero cells (p˂0.05). Saccharomyces boulardii
RC009 protected with M or WPC maintained viability after technological processing. It possesses a great capacity
for AFB1 adsorption and probiotic properties and could be considered a candidate with proven safety for func-
tional food products development.1. Introduction
Yeasts have been studied and used to make bread, beer andwine since
ancient times. Modern applications involve the production of ethanol,
single cell protein, food and fodder, production of heterologous enzymes
and proteins. They have also been used as biocontrol, bioremediation
agents, as indicators of environmental quality and used as probiotics in
animal nutrition to improve productive parameters and health (Rai and
Jeyaram., 2017; Poloni et al., 2020). In recent years, interest in its
beneficial therapeutic effects such as modulation of the immune system,
stimulation of goblet cells, prevention of gastrointestinal tract (GIT)
colonization by microbial pathogens adsorption of mycotoxins among
others, has been reported (Magnoli et al., 2019).
A problem associated with the microorganisms viability after
biotechnological purposes is their low resistance to technological pro-
cesses and different environmental conditions (Paez et al., 2012). Also,biología e Inmunología. Univer
Poloni), bbainotti@gmail.com (M
ntenegro), lcavaglieri@exa.unrc.
rm 17 February 2021; Accepted
evier B.V. This is an open access athe ability to survive the conditions of the GIT is of vital importance for
probiotic microorganisms since to exercise their beneficial effects on the
health of host they must remain alive. Probiotics are defined as “live
microorganisms which when administered in adequate amounts confer a
health benefit on the host” (FAO, 2013). Probiotics included into food-
stuffs are subject to stress factors such as temperature, acid and bile,
nutrient depletion, oxidative stress along with passage through the GIT
transit. Also, technological processes such as freezing process for the
development of ice crystals in the intercellular space or inside the cells,
drying entails losses in cell viability due to dehydration and osmotic
phenomena. These processes may detrimentally affect the probiotic
viability and functionality. Maintaining cell viability during drying is
critical to the successful production of probiotics. Several strategies have
been developed to generate a physical barrier that avoids exposure to
adverse environmental conditions, achieving stabilization, both in terms
of viability (ability to reproduce) and activity during its useful life.sidad Nacional de Río Cuarto. Ruta 36 Km.601, 5800, Río Cuarto, Cordoba,
.B. Bainotti), ladiazvergara@gmail.com (L.D. Vergara), fescobar@exa.unrc.edu.
edu.ar, lcavaglieri247@gmail.com (L. Cavaglieri).
18 February 2021
rticle under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
Table 1
Composition of commercial refinery syrup (CRS).
Specifications Minimum Maximum
Solids (%p/p) 76.5 77.5
Brix 74.8 75.8
IR 45 C 1.4716 1.4740
Density (kg/L) 1.3717 1.3780
SO2 (ppm) – 3.0
pH 3.3 4.3
Color (UI) – 20
Sulphated ash (%) – 0.05
Proteins (%) 0.08 0.08
Smell – taste Normal Normal
Viscosity 25 C (cP) – 1300
Sugar distribution (dry-based)
Levulosa (%) 55.0 –
Levulosa þ Dextrosa 95.0 –
*(refractometric, 20 C).
V.L. Poloni et al. Current Research in Food Science 4 (2021) 132–140Probiotic microorganisms are generally lyophilised or spray dried with
different lyoprotectants whose effectiveness varies according to the
microorganism to preserve (Díaz Vergara et al., 2017; Stefanello et al.,
2019). Previous studies showed that S. boulardii RC009 had the ability to
sequester AFB1 under GIT conditions. Also, it demonstrated to possess
beneficial properties to be considered as a probiotic microorganism
(Armando et al., 2011). Therefore, the objective of the present work was
to evaluate the influence of technological processing that involves pro-
tection strategies, protective materials and storage conditions, on the
viability, on probiotic properties and adsorbent AFB1 capacity of
S. boulardii RC009 after GIT transit. In addition, the biological safety of
the yeast was evaluated through cytotoxicity studies in Vero cell cultures.
2. Materials and methods
2.1. Microorganisms
Saccharomyces boulardii RC009 was obtained from the collection
centre at the Universidad Nacional de Río Cuarto, Argentina previously
isolated from foodstuffs and characterised by molecular techniques. For
coaggregation tests, pathogenic Escherichia coli, Salmonella spp., Staphy-
lococcus aureus, Streptococcus uberis y S. haemolyticus strains from the
collection of the Collection of the Laboratory of Industrial Microbiology
of the National University of Río Cuarto were used (Armando et al.,
2011).2.2. Culture conditions of Saccharomyces boulardii RC009. Kinetic and
productive parameters determination
Saccharomyces boulardii RC009 growth conditions were studied in a
culture medium with different concentrations of Commercial Refinery
Syrup (CRS) composed by levulose and dextrose solution obtained by the
cornstarch hydrolysis process, followed by enzymatic conversion and
subsequent refining (Table 1).
2.2.1. Growth conditions
An initial yeast inoculum from Yeast Peptone Dextrose agar (YPD - 40
g/L glucose, 5 g/L peptone, 5 g/L yeast extract) was taken with ansa,
seeded in YPD broth and incubated at 28 C for 24 h at 150 rpm. Ten mL
of this inoculumwere placed in 90 mL broth supplemented with different
concentrations of CRS as carbon source (30, 35, 40, 45, 55, 60, 70, 80,
and 90 g/L), 5 g/L peptone and 5 g/L yeast extract.
2.2.2. Kinetic parameters
The kinetic parameters (specific growth rate μx (h1) (Formula (1))
and doubling time td (h) (Formula (2)) were determined. Cell production
was monitored by optical density (OD 640 nm), after washing the cells133three times with physiological solution, centrifugation (5min, 5000 rpm)
and suspension. Cell viability was measured by counting cells in YPD
agar (CFU/g). Dry weight (g/L) determination was performed after
centrifugation and washing the cells with physiological solution, and
then dried in a forced air oven at 60 C to constant weight. Reducing






td ¼ ln 2μ (2)
2.2.3. Productive parameters
Productive parameters (maximum production (Xmax g/L), maximum
productivity (Pmax-g/L.h) and Yield (Yx/s - Formula (3)) were
determined.
Yx=s ¼ Biomass ðg=LÞSubstrate consumption ðg=LÞ (3)
2.3. Technological procedures
2.3.1. Dried by lyophilisation of S. boulardii RC009 (DL)
The yeast biomass was centrifuged for 10 min at 4000 rpm. The
following protectants: derivatized chitosan conditioned according to
Diaz Vergara et al. (2017), skim milk 10% (w/v), maltodextrin (M) 2.5%
(w/v), and whey protein concentrate (WPC) (5% (w/v) were added
separately in a 1:1 ratio. The protected biomass was incubated at 80 C
and then, lyophilised in a four-necked drum-type laboratory lyophilizer
(Rificor mod L-T4). The process started at 45 C at a working pressure
of 0.001 Pa.
2.3.2. Saccharomyces boulardii RC009 encapsulation by ionic gelation and
subsequent lyophilisation (EL)
Yeast encapsulation and subsequent lyophilisation was performed
according to Díaz Vergara et al. (2017) with some modifications.
Atomisation was achieved by forcing the dispersion of a mixture (sodium
alginate 1% þ 3 mL 7.7  109 CFU/mL S. boulardii RC009) through the
spray nozzle over the gelling medium (Cl2Ca 1%). The particles were
kept stirred for 30 min in the Cl2Ca solution to ensure complete gelation.
Then, they were removed using a sterile sieve and washed with sterile
distilled water. The capsules obtained were protected with M 2.5% (w/v)
and WPC (5% (w/v) as lyoprotectants in a 1:1 ratio, and subsequently
lyophilised as mentioned above.
2.4. Post-technological procedures assays
The influence of technological processes on S. boulardii RC009
viability and functionality was studied. The viability over time was car-
ried out after simulating different storage conditions and the passage
through GIT. Then, probiotic and aflatoxin B1 adsorbent properties were
evaluated.
2.4.1. Storage conditions
The obtained DL were stored at 4 C and 25 C to simulate cooling
temperatures and atmosphere, respectively, for 7 and 30 d to determine
the viability after the lyophilisation process according to Poloni et al.
(2017). Based on the results obtained, the protectants that demonstrated
the best ability to preserve cell viability were subjected to a new viability
test at 4 C and 25 C for 70 d storage. The obtained EL were stored at 4
C and 25 C for 90 d and viability was determined according to Díaz
Vergara et al. (2017).
V.L. Poloni et al. Current Research in Food Science 4 (2021) 132–1402.4.2. Scanning electron microscopy
The DL and EL S. boularddii were processed for Scanning Electron
Microscopy (SEM) according to Díaz Vergara et al. (2017). All samples
were pre-fixed in 3% (w/v) glutaraldehyde in 0.1 M sodium phosphate
buffers, pH 7.2 for 3 h followed by thorough washing with phosphate
buffer. Fixed materials were then post-fixed in 1% aqueous osmium te-
troxide for 3 h. Dehydration of samples was achieved by transferring to
vials containing a graded water–acetone series (10% steps for 30–90%
each of 60 min, 100% for 180 min and finally 100% overnight). Dehy-
drated specimens were embedded with Embed 812 and acetone 100% by
24 h, then were embedded with EMbed 812 with 1.5% hardening agent,
DMP-30 at 60 C by 24 h. Ultra-thin sections (60 nm) were cut and placed
on copper grids, counterstained with saturatedmuranyl acetate and
aqueous lead citrate. Morphology and size distribution of spray-dried
were evaluated by SEM with a ZEISS SIGMA VP Field Emission SEM
(FE-SEM) (ZEISS, Germany), using an acceleration voltage of 5 kV. MCs
were fixed in stubs containing a double-faced adhesive metallic tape and
coated with gold in a CED 010 vacuum evaporator (Balzers Union,
Liechtenstein).
2.4.3. Viability maintenance through gastrointestinal tract transit
The effect on DL and EL cell viability against the stress generated by
passing through GIT was simulated as follows: tolerance to artificial
salivary solution (KCl 15.1 mM; KH2PO4 3.7 mM; NaHCO3 13.6 mM;
NaCl 23 mM; MgCl2 0,15 mM; (NH4)2HCO3 0.06 mM; Urea 7.5 mM; HCl
1.1 mM; α-amylase 1500 U/mL; lysozyme 12000 U/mL; CaCl2 0,75 mM),
tolerance to artificial gastric juice (KCl 6.9 mM; KH2PO4 0.9 mM;
NaHCO3 25.0 mM; NaCl 47.2 mM; MgCl2 0.1 mM; (NH4)2HCO3 0.5 mM;
Urea 0.2 mM; HCl 15.6 mM; pepsin 25000 U/mL; lysozyme 12000 U/mL;
CaCl2 3.3 mM) and tolerance to artificial intestinal content (KCl 6.8 mM;
KH2PO4 0.8 mM; NaHCO3 85.0 mM; NaCl 38.4 mM; MgCl2 0.33 mM;
urea 1.8 mM; HCl 8.4 mM; trypsin 1600 U/mL; chymotrypsin 400 U/mL;
CaCl2 0,03 mM; biliar juice 833 μl). An ON culture was performed in YPD
broth at 28 C for 24 h which contained an initial inoculum of cells (II).
The culture (1 mL) was taken, centrifuged for 10 min at 5000 rpm; the
obtained pellet was resuspended in 1.4 mL of saliva solution, and
adjusted to pH 6.8 with 0.1 M HCl. The cells were incubated at 37 C for
2 min at 250 rpm. After incubation, an aliquot of 100 μL was taken
(salivary conditions - SC) to which 2.6 mL of gastric solution was added
and adjusted to pH 3 with 1 M HCl. The tubes were incubated at 37 C for
2 h at 250 rpm and 100 μl were taken (gastric conditions - GC). Intestinal
solution (4.4 mL) was added to the cells and adjusted to pH 7. The tubes
were incubated at 37 C for 2 h at 250 rpm. At the end of the incubation
period an aliquot of 100 μl was taken (intestinal conditions - IC). Serial
dilutions in peptone water (0.1%) were obtained with all samples; then,
100 μl aliquots of each dilution were plated on YPD agar for viable cell
count. Assays were conducted in triplicate.
2.4.4. Probiotic abilities maintenance of Saccharomyces boulardii RC009
The influence of the technological procedures on probiotic properties
of lyophilised cells such as aggregation, coaggregation, and antimicrobial
substances production was tested.
2.4.4.1. Autoaggregation ability. Lyophilised cells (0.1 g) were resus-
pended in 2 mL of PBS buffer (0.2 M pH 7.2). The suspension was vor-
texed for 30 s and OD at 600 nm was measured in a spectrophotometer.
Then, they were incubated at 28 C for 2 h; the upper layer (1 mL) was
transferred to an Eppendorf tube and the OD was determined again.
2.4.4.2. Coaggregation to pathogenic bacteria. Yeast coaggregation ca-
pacity with pathogenic microorganisms isolated from the animal
ecosystem such as Escherichia coli, Salmonella spp, Staphylococcus aureus,
Streptococcus uberis and Streptococcus haemolyticus was evaluated.
Lyophilised cells were resuspended in 2 mL PBS buffer (0.2 M pH 7.2)
and the final concentration was adjusted to approximately 109 cell/mL134by turbidity comparison with tube 4 of the McFarland scale. Pathogenic
strains suspensions were carried out in PBS buffer (1 M pH 6.2) and the
final concentration was adjusted to approximately 109 cel/mL by
turbidity comparison with tube 4 of the McFarland scale. Yeast was
mixed (1:1) with each of the pathogens separately in Eppendorf tubes
and incubated at 37 C for 3 h. Suspensions were then observed by optic
microscopy after Gram staining to evaluate the aggregation degree and
scored according to a scale as follows: (no aggregation), þ (little aggre-
gation), þþ (intermediate aggregation) and þþþ (maximum
aggregation).
2.4.4.3. Antibiotic resistance. Lyophilised cells were resuspended in 2 mL
of PBS buffer (0.2 M pH 7.2) and the final concentration adjusted by
turbidity comparison with tube 0.5 on the McFarland scale. The sus-
pension was seeded by swabing (in different directions) in a Petri dish
with 4 mm YPD agar. The antibiotics used in this trial were gentamicin,
kanamycin, amoxicillin þ clavulanic acid, and colistin, selected for their
frequent use in veterinary medicine. The antibiotic disks were placed on
the agar, equidistant from each other and from the edge of the plate.
Then, the plates were incubated at 28 C for 24 h. The antibiograms were
read based on the presence or absence of an inhibition halo around the
disc.
2.4.5. Aflatoxin B1 adsorption ability maintenance during gastrointestinal
tract transit
The AFB1 adsorption assay of DL and EL S. boulardii RC009 was
performed according to Armando et al. (2011) with some modifications.
Two AFB1 concentrations (20 and 50 ng/mL) ere tested which were in
contact with yeast cells (107 cell/mL). An Eppendorf tube containing the
SS (1 mL) with each concentration of AFB1 separately was exposed with a
pellet of ON yeast culture (107 cell/mL grown in YPD broth at 28 C for
24 h) and incubated at 37 C for 2 min. Subsequently, the tubes were
centrifuged for 10 min at 5000 rpm, the supernatant was removed and
the obtained pellets were exposed to GC at 37 C for 2 h and then,
centrifuged at 5000 rpm for 10 min. The supernatant was removed.
Finally, the obtained pellets were exposed to 1 mL IC, mixed with vortex
and incubated at 37 C for 2 h at 250 rpm. The tubes were centrifuged
(10 min, 5000 rpm) and the supernatant was removed and stored at 20
C until its subsequent analysis by HPLC for AFB1 determination.
The analysis of the amount of free AFB1 in the supernatants (non-
adsorbed toxin) previously obtained was performed by HPLC with a
fluorescence detector (FLD) according to Trucksess et al. (1994). Each
sample (200 μL) was placed in 700 μL of acetic acid-trifluoroacetic
acid-water (20:10:70) solution. Subsequently, they were incubated at
65 C for 8.5 min, left to rest for 10 min, and each solution was injected
into the HPLC equipment. A control of each sample and standard solu-
tions were included to perform the calibration curve. The conditions of
the chromatographic run were C18 Luna column (150  4.6 mm, 5 μm);
fluorescence detector: 360 ηm excitation, 440 ηm emission; the mobile
phase used was water: acetonitrile:methanol (4:1:1 v/v); flow 1.5
mL/min; injection volume 20 μL, the retention time of the samples was
5.5 min. A calibration curve with AFB1 standards (Sigma) was performed.
The amount of adsorbed toxin was determined by the difference between
the concentration of free toxin in the supernatant and the initial con-
centration of AFB1 placed.
2.5. Biosafety assays. Citotoxicity
Saccharomyces boulardii RC009 was subjected to cytotoxicity tests, in
order to verify that this strain does not have cytotoxic effects. A Vero cell
line, clone 76 (continuous line of African green monkey kidney, Chlor-
ocebus sp.) was acquired from the Asociacion Banco Argentino de Celulas
(ABAC - Pergamino, Buenos Aires, Argentina). The cells were kept in
growth medium forming monolayers until use.
Fig. 1. Growth rate of Saccharomyces boulardii RC009 (Ln) and residual glucose (g/L) as a function of time in Commercial Refinery Syrup (CRS) medium.
Table 2
Kinetic and productive parameters of Saccharomyces boulardii RC009 growing in
commercial refinery syrup (CRS) culture medium as carbon source.
Kinetic parametersa Productive parameters
Growth rate (μmax) (h1) 0.2860 Maximum harvest (g) 3.9
Doubling time (Td) (h) 2.42 Productivity (g/L/h) 0.397 (9.83 h)
Yield (g/L) 13.40
a Kinetic parameters were calculated from dry weight determination.
V.L. Poloni et al. Current Research in Food Science 4 (2021) 132–1402.5.1. Determination of the Maximum Non-Cytotoxic Concentration
To determine the Maximum Non-Cytotoxic Concentration (MNCC),
confluent cell cultures grown in 96-well polycuvettes that were incu-
bated, in independent tests, were carried out with maintenance medium
(MM) containing different yeast concentrations according to Escobar
et al. (2019) with some modifications. Cell monolayers bathed only with
MM without yeasts were used as an indicator of normal cell morphology.
Control and treated cultures were kept in an oven at 37 C for 24 h and
examined under an inverted light microscope. The MNCC was defined as
the maximum concentration that did not generate any visible alteration
in the cellular system used.
2.5.2. Cytotoxic concentration determination
The cytotoxic concentration determination (CC50) was monitored
using the Neutral Red (RN) uptake test. Vero cells were seeded in 96-well
polycuvettes at a concentration 104 cell/well in minimal essential me-
dium (MEM; Gibco, USA) supplemented with 8% foetal calf serum (FCS;
Natocor, Argentina), gentamycin 50 μg/mL and 2 mM glutamine (Sigma-
Aldrich, Italy) and incubated at 37 C for 24 h. The subconfluent cell
monolayers were treated for the next 24 h with different concentrations
of the yeast (104; 105; 106; 107; 108 cell/mL), in quadruplicate. The so-
lutions were removed from the plates and the cells were washed with
200 μl PBS/well. Then, 200 μl/well of RN solution (30 μg/mL inMM)was
added and the plate was incubated at 37 C for 3 h to favor the incor-
poration of the dye to the cells. At the end, the cells were washed 3 times
with PBS. The dye within the cells was released by extraction with a
mixture of acetic acid, ethanol, and water (1:50:49). After stirring the
cultures for 20 min, the absorbance values (OD540) were measured in a
microplate reader (Labsystems Multiskan MS). The system included un-
treated cells as control. The relative viability in the treatments was
expressed as a percentage decrease in RN uptake in relation to the control
cells. The percentage of cell viability was determined according to for-
mula (4):
% Viability¼ OD treated cells
OD control cells
x 100 (4)
3. Results and discussion
3.1. Kinetic and productive parameters of Saccharomyces boulardii RC009
growth
Different CRS concentrations were tested and 30 g/L concentration
showed the best results (data not shown). One biotechnological aspects
of biomass production involve the design or selection of the culture
medium, which must meet all the nutritional requirements that allow an
adequate growth. Also, it would be available on the market and obtained135as by-product from some industrial process. Fig. 1 shows the growth of
S. boulardii RC009 in CRS medium and the consumption of reducing
sugars as a function of time. The yeast showed amaximum growth at 10 h
incubation (3.3  108 cell/mL). The reducing sugars consumption
increased significantly after 4 h and reached the maximum consumption
when the cells production was maximum (3.9 g/L). The yeast showed a
lag phase of approximately 2.5 h allowing it to adapt to the culture
medium. Microbial biomass is widely used for different purposes such as
fermentation starter cultures and inocula for food and beverage fer-
mentations, as well as a source of protein for human consumption, since
it can be formulated in a wide range of foods; and also for the elaboration
of animal feed additives, such as probiotics.
Table 2 shows the kinetic and productive parameters obtained from
the growth of the yeast in CRS. The kinetic parameters as specific growth
rate (μmax) and doubling time (Td) were 0.2860 h1 and 2.42 h, respec-
tively. Regarding production parameters, the maximum biomass pro-
duction was 3.9 g/L at 9.83 h. Aguilar et al. (2015) working with
S. cerevisiae in a medium with molasses and whey obtained lower kinetic
parameters than those obtained in this study. The industrial production
of S. boulardii as a probiotic must ensure that the used processing tech-
nologies guarantee its stability, both in terms of viability (ability to
reproduce) and activity during its useful life. In the present work, the CRS
composed by levulose and dextrose allowed achieving high kinetic and
productive parameters, making this carbon source promising for indus-
trial use.3.2. Saccharomyces boulardii RC009 viability after lyophilisation
Yeasts generally have greater resistance to environmental changes
(pH gradients, osmotic changes, etc.) than lactic bacteria, as well as lower
nutritional requirements that result in lower costs in production pro-
cesses. In addition, the greater acid tolerance of yeasts is an important
advantage, both in fermentations (since it reduces the risk of bacterial
contamination), and in the probiotic quality of the product obtained. All
these factors would be beneficial during the production stage, as well as
during storage and consumption (Singh et al., 2005).
Protectants such as derivatized chitosan, skim milk; M and WPC were
Table 3
Saccharomyces boulardii RC009 viability after lyophilisation with maltodextrin
and whey protein concentrate as protectants and stored at 4 C y 25 C during
different time periods.
Time (days) Lyophilised Saccharomyces boulardii RC009 viability (CFU/g)
Maltodextrin Whey Protein Concentrate
4 C 25 C 4 C 25 C
0 6.6  1010 1.7  1010 9.3  1012 9.3  1012
30 3.0  1010 4.5  109 1.0  1011 2.3  108
70 6.5  109 1.7  109 3.5  1010 0
Table 4
Saccharomyces boulardii RC009 viability (CFU/g) after encapsulation with
different protectants and lyophilisation, and stored at 4 C and 25 C during
different time periods.
Time (days) Encapsulated and lyophilised Saccharomyces
boulardii RC009 viability (CFU/g)
Maltodextrin Whey Protein
Concentrate














































The results are expressed as colony forming units (CFU)/g lyophilisate.
V.L. Poloni et al. Current Research in Food Science 4 (2021) 132–140used to eliminate the thermal and osmotic damage caused by the treat-
ments. The lyophilisation process reduced the viability of the yeast cells
by 3 logs when they were protected with derivatized chitosan or skim
milk, whereas when M or WPC were used, the highest cell viability was
achieved (data not shown). Based on these results, it was decided toFig. 2. Scanning electron microscopy (SEM) of Saccharomyces boulardii RC009 *pr
lyophilisation (DL) or encapsulation þ lyophilisation (EL) methodologies after gastro
(scale bar ¼ 1 μm); C) DL þ WPC 1 Kx (scale bar ¼ 10 μm); D) DL þ WPC 5 Kx (scale
μm); G) EL þ WPC 1 Kx (scale bar ¼ 10 μm); H) EL þ M 5 Kx (scale bar ¼ 2 μm).
136repeat the viability test with M and WPC at a longer preservation time.
Table 3 shows the viability of lyophilised S. boulardii RC009 with M and
WPC, stored at 4 C and 25 C for 70 d. When the yeast was stored at 4 C,
cell viability was reduced 1 log protectedwithM and 2 log protected with
WPC. When S. boulardii RC009 was stored at 25 C with M the viability
was reduced 1 log after 70 d conservation; however, with WPC the
viability was significantly reduced (3 log) after 30 d; no live cells were
recovered after 70 d of the test. Trials carried out by Stefanello et al.
(2019) showed a marked difference in the ability to maintain cell
viability of yeasts and bacteria protected with different materials and
lyophilised, the protection of L. fermentum with skim milk supplemented
with glutamate achieved a viability of 87% for one year, while for
Wickerhamomyces anomalus the viability was reduced. When sucrose was
used as a protective agent, it was able to maintain the viability of
W. anomalus for one month and 2 months for L. fermentum.
3.2.2. Saccharomyces boulardii RC009 viability of after encapsulation and
lyophilisation using different protectants
In this work, two technological processes were carried out, a DL
process and EL one. The lyophilisation process was applied both, to DL
and EL yeasts. Protection with M and WPC were the most efficient in
ensuring that these technological processes did not affect the yeast
viability, decreasing in general 2 log after 90 d storage. Table 4 shows
S. boulardii RC009 viability (CFU/g) before (2.3  1011 CFU/g) and after
EL and stored at 4 C and 25 C during different time periods. Yeast
counts reduced 3 log in all treatments in general after 90 d storage at 4 C
and 25 C. Similar results were obtained by Díaz Vergara et al. (2017)
who obtained a decrease of 2–3 log after 90 d storage of Kluyveromyces
marxianus encapsulated with derivatized chitosan. Other authors have
shown that microencapsulated yeast strains coated with whey protein
obtained 98% viability after 60 d storage (Ragavan and Das, 2018). On
the other hand, Chandralekha et al. (2016) evaluated the viability of
S. cerevisiae protected with M and then sprayed and observed a reduction
of 3 log after 14 d storage.
3.2.3. Scanning electron microscopy
Fig. 2 shows the SEM of yeast protected with M and WPC, after DL or
EL. The microphotographs show agglomerations of yeasts arranged in a
network with a slightly rough surface (Fig. 2B. and 2.D.). Both pro-
tectants used for DL showed the formation of laminae and the cellsotected with maltodextrin (M) and whey protein concentrate (WPC) applying
intestinal tract passage. A) DL þ M 1 Kx (scale bar ¼ 10 μm); B) DL þ M 5 Kx
bar ¼ 1 μm). E) EL þ M 1 Kx (scale bar ¼ 10 μm); F) EL þ M 5 Kx (scale bar ¼ 1
Table 5
Influence of simulated gastrointestinal tract transit on Saccharomyces boulardii
RC009 viability after technological procedures (lyophilisation or encapsulation
þ lyophilisation).
Technological treatments Log10 CFU during simulated
gastrointestinal transit a
II SC GC IC
Lyophilisation M b 9.10 7.66 6.93 6.30
WPC c 9.10 7.56 7.25 6.90
Encapsulation þ Lyophilisation M 6.75 5.60 5.02 4.78
WPC 6.93 5.70 4.95 4.40
II: initial inoculum, SC: Salivary conditions tolerance assay, GC: Gastric condi-
tions tolerance assay, IC: Intestinal conditions tolerance assay.
a CFU: colony forming units.
b M: Maltodextrin.
c WPC: Whey protein concentrate.
Table 6
Autoaggregation ability of Saccharomyces boulardii RC009 before and after lyo-








Yeast before lyophilisation 1.173 0.0253 97.9
Yeast after
lyophilisation





b WPC: whey protein concentrate.
V.L. Poloni et al. Current Research in Food Science 4 (2021) 132–140arranged between them (Fig. 2A. and 2.C.). When S. boulardii RC009 was
EL rounded encapsulates were observed with a smooth textured surface
(Fig. 2F. and 2.H.), immersed in layers formed by the protective sub-
stances (Fig. 2E. and 2.G.). They were found viable and in a budding
process.
3.3. Post-technological processes assays
3.3.1. Dried by lyophilisation or encapsulated and lyophilised
Saccharomyces boulardii RC009 viability after gastrointestinal transit
The ability to survive under simulated GIT conditions is an absolute
requirement for probiotic microorganisms, and is generally included
among the criteria used to select microorganisms with probiotic ability
(Sarao and Arora, 2015). Table 5 shows the viability of DL or EL
S. boulardii RC009 protected with M or WPC after GIT transit. Yeast
without treatment was not significantly reduced after simulated GIT
transit. Salivary conditions reduced 2 log the DL yeast counts protected
with M and GC followed by IC reduced another 1 log. When cells were DL
and protected with WPC also reduced 2 log the yeast counts, which were
maintained under GC and IC. Salivary conditions reduced 1 log the EL
counts protected with M or WPC wheras GC and IC reduced 1 log the
yeast counts. Saliva has significant amounts of lysozyme, a kind of nat-
ural enzyme with antimicrobial properties. The functional properties of
proteins could be affected in the presence of different polysaccharides.
Xu et al. (2018) investigated the influences on structure and activity of
lysozyme in the presence of different polysaccharides and provided
useful information for its application in food preservation with antimi-
crobial activity regulation. They indicated the interaction between
polysaccharide and lysozyme strengthened as the concentration of lyso-
zyme increased resulting in changing its secondary structure; in the
presence of konjac glucomannan and inulin the lysozyme activity
remained constant but in the presence of κ-carrageenan the lysozyme
activity was reduced probably because strong electrostatic interaction
between κ-carrageenan and lysozyme could be induced resulting in
spatial structure changing. Studies concerning the interactions between
M and chitosan and lysozyme have not been reported but probably an
interaction that positively induce the enzyme activity could increase the
antimicrobial effect on the yeast that was significantly reduced under the
SC in this work.
Based on these results, the levels of viable cells should reach 1010 CFU
before the application of protectants to obtain viable levels of S. boulardii
RC009 to be considered an effective probiotic. The recommended dose
for most probiotic strains is 108–109 CFU/kg food (Simon et al., 2005).
These results were similar to those obtained by Armando et al. (2011)
who used the same yeast S. boulardii RC009 without technological
processing.
Studies carried out Suryabhan et al. (2019), reported that cell counts
of yeast strains encapsulated with M and then coated with sucrose or
sorbitol increased after passage through gastric and bile juices. Tests137performed with lactic acid bacteria sprayed and protected with 20% skim
milk þ WPC or starch showed an improvement in cell survival of 1.5 log
compared to fresh culture in simulated GIT digestion (Paez et al., 2012).
3.3.2. Probiotic properties of dried by lyophilisation or encapsulated and
lyophilised Saccharomyces boulardii RC009
3.3.2.1. Autoaggregation. Table 6 shows the autoaggregation ability of
S. boulardii RC009 before and after lyophilisation procedure (DL and EL)
using M orWPC as protectants. The yeast before lyophilisation procedure
obtained a high percentage of aggregation (97.9%) compared to cells
after lyophilisation procedure (DL or EL), which obtained very low per-
centages of aggregation when they were protected with M (28%) or with
WPC (22%).
The ability of autoaggregation or the formation of multicellular
groups between microorganisms of the same strain is a measure of the
ability to adhere to epithelial cells that could be related to the formation
of biofilms. The aggregation property can be shown in two different
ways, as autoaggregation, where cells of the same species agglomerate,
and as coaggregation, when it gives rise to the union of different mi-
croorganisms (Kragh et al., 2016). In the present work, the ability to
autoaggregate and coaggregate cells by yeasts after the technological
process was studied. It was observed that the strain did not show an
autoaggregative phenotype. As far as has been read in the literature, no
results related to autoaggregation and coaggregation properties of pro-
biotic yeasts after encapsulation have been reported yet. Armando et al.
(2011) had already reported aggregation properties of this same strain,
which showed the decrease of this property after technological process-
ing in the present work. The adhesion of probiotic strains varies among
strains, depending on the cell surface properties such as hydrophobicity
and extracellular protein profiles. The hydrophobic⁄hydrophilic, electron
donor (basic) and electron acceptor (acidic) characteristics are attributed
to carboxylic groups and Lewis acid – base interactions of bacterial sur-
face (proteins and polysaccharides) (Kos et al., 2003). These groups were
probably hidden under the layer of the lyoprotectant or encapsulating
material.
3.3.2.2. Coaggregation. Table 7 shows the coaggregation ability of
S. boulardii RC009 against pathogenic strains, before and after lyophili-
sation procedure as protectants. The yeast before lyophilisation proced-
ure was not capable of coaggregating pathogens or has very using M or
WPC low coaggregation capacity (Salmonella sp.). After lyophilisation
procedure cells (DL or EL) using M or WPC a high capacity to form
coaggregates was observed with all the pathogens studied. Furthermore,
when cell protection was performed with M, the highest degree of
coaggregation for most of the studied pathogens was obtained.
The coaggregation property is related to the autoaggregation ability
of each strain (Xu et al., 2009). However, in the present work, techno-
logical processing improved the coaggregation capacity of pathogens.
Probably, the pathogenic microorganisms presented higher
co-aggregation than the probiotics, suggesting specific binding capabil-
ities and indirectly preventing their GIT colonization.
Table 7
Coaggregation ability of Saccharomyces boulardii RC009 against pathogenic strains, before and after lyophilisation procedure using maltodextrin or whey protein
concentrate as protectants.
Treatments Pathogenic strains
E. coli Salmonella sp. S. aureus S. uberis S. haemolyticus
Yeast before lyophilisation – þ ND ND ND
Yeast after lyophilisation M a þþþ þþþ þþþ þþ þþþ
WPC b þ þþþ þ þþþ þ
() Absence of coaggregation in 5 randomly observed fields. (þ) Presence of coaggregation in 1 of 5 fields observed at random. (þþ) Presence of coaggregation in 2–3 of
5 fields observed at random. (þþþ) Presence of coaggregation in 4–5 of 5 fields observed at random. ND: not determined.
a M: maltodextrin.
b WPC: whey protein concentrate.
Fig. 3. Aflatoxin B1 adsorption (20 and 50 ng/mL) by S. bouladii RC009 protected with maltodextrin (M) and whey protein concentrate (WPC) applying lyophilisation
or encapsulation þ lyophilisation methodologies after gastrointestinal tract passage.
Fig. 4. Vero cells viability (%) determined by neutral red uptake after treatment
with different concentrations of Saccharomyces boulardii RC009 (104-108 cells/
mL). A) Vero cells in monolayers after control and Saccharomyces boulardii 104 to
106 cells/mL treatments, B) Vero cells in monolayers after Saccharomyces bou-
lardii 107 and 108 cells/mL treatments. *p ˂ 0.05 according to Fisher’s Least
Significant Difference test. (For interpretation of the references to colour in this
figure legend, the reader is referred to the Web version of this article.)
V.L. Poloni et al. Current Research in Food Science 4 (2021) 132–1403.3.2.3. Antibiotic resistance. Saccharomyces boulardii RC009 (DL and EL)
protected with M or with WPC and after the lyophilisation process,
demonstrated resistance to all the antibiotics tested (data not shown).
The natural antibiotic resistance of yeast is an important characteristic
for their use as probiotics (Czerucka et al., 2007). Bacterial resistance can
be passing to other bacteria vertical and/or horizontal, through genes
transference between bacteria. The main threat associated to probiotic
bacteria is the capacity of transfer resistance gene to pathogenic bacteria.
Because there is no genetic transference between bacteria and yeasts, its
use as probiotic is safe and advantageous. In this work, S. boulardii RC009
showed resistance to all the antibiotics analyzed. It is important to
highlight that they must show activity against bacteria, and not against
yeasts. This is beneficial since when applying one of these antibiotics to
livestock, the yeast would not be affected, so it could remain in the an-
imal’s intestine and develop normally. Previous studies have already
shown that antibiotics for veterinary use did not exert a negative influ-
ence on probiotic yeasts (Poloni et al., 2017).
3.4. Aflatoxin B1 adsorption by dried by lyophilisation or encapsulated
and lyophilised Saccharomyces boulardii RC009 during gastrointestinal
tract transit
The AFB1 adsorption assay was performed with two concentrations
20 and 50 ng/mL AFB1 using DL or EL of S. boulardii RC009 during GIT
transit. Fig. 3 shows DL yeasts protected with M andWPC had the highest
adsorption percentages (79.5% and 86.7% respectively), and at the
highest AFB1 concentration used (50 ng/mL).
The EL yeasts showed the same tendency but in all cases the138
V.L. Poloni et al. Current Research in Food Science 4 (2021) 132–140adsorption percentages were lower. At 50 ng/mL AFB1, EL yeasts showed
the highest adsorption percentage (40%). Mycotoxin adsorbents can be
used to control mycotoxins in the diet. The binding of the adsorbents
with the mycotoxins reduce their bioavailability (Yanikouris et al.,
2006). The results obtained in the present work showed that the yeast
S. boulardii RC009 subjected to technological processes achieved high
percentages of AFB1 adsorption when it was lyophilised. Previous studies
showed that the same strain working 50 ng/g AFB1 without technological
processing had adsorption levels of 16.4% (Armando et al., 2011). The
increase in the percentage of adsorption observed in this work was
related to the cell protectants used. The DL process allowed a greater
adsorption of mycotoxin than the EL process; probably the alginate did
not allow the exposure of the yeast cells because the conditions of the GIT
did not allow its adequate dissolution.
3.5. Biological safety test: maximum non-cytotoxic concentration and
cytotoxic concentration 50%
Fig. 4 shows Vero cells viability (%) determined by neutral red uptake
after treatment with different concentrations of S. boulardii RC009.
Cytopathic effect observed under the light microscope demonstrated that
cells treated with 104 cell/mL to 106 cell/mL S. boulardii RC009 did not
excise cellular damage, showing the absence of toxicity at these con-
centrations and percentage viability values similar to the negative con-
trol. Fig. 4A. shows S. boulardii RC009 cells without morphological
alterations, while the concentrations of 107 cell/mL and 108 cell/mL
altered cell morphology (Fig. 4B.) and exhibited significantly lower cell
viability values compared to the control treatment cells viability. The
Vero cells viability percentage determined by uptake of neutral red (RN)
after treatment with S. boulardii RC009 at different concentrations
showed 9  106 cell/mL as the 50% cytotoxic concentration (CC50)
calculated by the intrapolation of the dose-response curve. The results
were expressed as percentage of cellular viability compared to the control
treatment.
One of the criteria to consider a probiotic microorganism is that it is
not toxic to the cell. In this study, Vero cells were exposed to different
concentrations of S. boulardii. Assay carried out by Gonzalez-Pereyra
et al. (2014) in mice with S. cerevisiae indicated that oral administration
(109 CFU/mL) of yeast did not cause cytotoxic effects, the animals did not
show any health damage. Also, Zommiti et al. (2018) showed 96%
Caco-2/CT7 cell viability with a potential probiotic Enterococcus faecium.
4. Conclusion
This study suggests that substrates that come from the agro-industry
can be used for biomass production, contributing to the sustainable
development of the process and reducing the costs of large-scale pro-
duction. Saccharomyces boulardii RC009 after DL or EL technological
processing protected with M or WPC could be considered as probiotic
candidate with proven safety and promissory for the development of
functional products since it possesses great capacity for AFB1 adsorption
and, at the same time, effectively preserves the desired probiotic
properties.
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